Works matching IS 03065251 AND DT 1988 AND VI 25 AND IP 4
1
- British Journal of Clinical Pharmacology, 1988, v. 25, n. 4, p. 477, doi. 10.1111/j.1365-2125.1988.tb03332.x
- Edwards, G;
- Looareesuwan, S;
- Davies, AJ;
- Wattanagoon, Y;
- Phillips, RE;
- Warrell, DA
- Article
2
- British Journal of Clinical Pharmacology, 1988, v. 25, n. 4, p. 425, doi. 10.1111/j.1365-2125.1988.tb03325.x
- Maclean, D;
- Mitchell, ET;
- Coulson, RR;
- Fitzsimons, TJ;
- McDevitt, DG
- Article
3
- British Journal of Clinical Pharmacology, 1988, v. 25, n. 4, p. 509, doi. 10.1111/j.1365-2125.1988.tb03336.x
- Johnston, A;
- Marsden, JT;
- Holt, DW
- Article
4
- British Journal of Clinical Pharmacology, 1988, v. 25, n. 4, p. 453, doi. 10.1111/j.1365-2125.1988.tb03329.x
- Owens, DR;
- Vora, JP;
- Birtwell, J;
- Luzio, S;
- Hayes, TM
- Article
5
- British Journal of Clinical Pharmacology, 1988, v. 25, n. 4, p. 465, doi. 10.1111/j.1365-2125.1988.tb03331.x
- Murray, GI;
- Barnes, TS;
- Sewell, HF;
- Ewen, SW;
- Melvin, WT;
- Burke, MD
- Article
6
- British Journal of Clinical Pharmacology, 1988, v. 25, n. 4, p. 417, doi. 10.1111/j.1365-2125.1988.tb03324.x
- Deering, AH;
- Riddell, JG;
- Harron, DW;
- Shanks, RG
- Article
7
- British Journal of Clinical Pharmacology, 1988, v. 25, n. 4, p. 505, doi. 10.1111/j.1365-2125.1988.tb03335.x
- Eichelbaum, M;
- Bertilsson, L;
- Kupfer, A;
- Steiner, E;
- Meese, CO
- Article
8
- British Journal of Clinical Pharmacology, 1988, v. 25, n. 4, p. 445, doi. 10.1111/j.1365-2125.1988.tb03328.x
- Arnout, J;
- Hecken, A;
- Lepeleire, I;
- Miyamoto, Y;
- Holmes, I;
- Schepper, P;
- Vermylen, J
- Article
9
- British Journal of Clinical Pharmacology, 1988, v. 25, n. 4, p. 523, doi. 10.1111/j.1365-2125.1988.tb03339.x
- Rodgers, A;
- Woodhouse, KW;
- Bateman, DN
- Article
10
- British Journal of Clinical Pharmacology, 1988, v. 25, n. 4, p. 457, doi. 10.1111/j.1365-2125.1988.tb03330.x
- Clausen, TG;
- Wolff, J;
- Hansen, PB;
- Larsen, F;
- Rasmussen, SN;
- Dixon, JS;
- Crevoisier, C
- Article
11
- British Journal of Clinical Pharmacology, 1988, v. 25, n. 4, p. 405, doi. 10.1111/j.1365-2125.1988.tb03323.x
- Cooper, RG;
- Stokes, MJ;
- Edwards, RH;
- Stark, RD
- Article
12
- British Journal of Clinical Pharmacology, 1988, v. 25, n. 4, p. 495, doi. 10.1111/j.1365-2125.1988.tb03334.x
- Article
13
- British Journal of Clinical Pharmacology, 1988, v. 25, n. 4, p. 439, doi. 10.1111/j.1365-2125.1988.tb03327.x
- Poitevin, B;
- Davenas, E;
- Benveniste, J
- Article
14
- British Journal of Clinical Pharmacology, 1988, v. 25, n. 4, p. 518, doi. 10.1111/j.1365-2125.1988.tb03338.x
- Manara, AR;
- Shelly, MP;
- Quinn, K;
- Park, GR
- Article
15
- British Journal of Clinical Pharmacology, 1988, v. 25, n. 4, p. 525, doi. 10.1111/j.1365-2125.1988.tb03340.x
- Donnelly, R;
- Elliott, HL;
- Meredith, PA
- Article
16
- British Journal of Clinical Pharmacology, 1988, v. 25, n. 4, p. 487, doi. 10.1111/j.1365-2125.1988.tb03333.x
- Article
17
- British Journal of Clinical Pharmacology, 1988, v. 25, n. 4, p. 433, doi. 10.1111/j.1365-2125.1988.tb03326.x
- Robb, OJ;
- Webster, J;
- Petrie, JC;
- Harry, JD;
- Young, J
- Article
18
- British Journal of Clinical Pharmacology, 1988, v. 25, n. 4, p. 514, doi. 10.1111/j.1365-2125.1988.tb03337.x
- Parish, RC;
- Gotz, VP;
- Mehta, JL
- Article